These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 23345451)
1. Total cellular glycomics allows characterizing cells and streamlining the discovery process for cellular biomarkers. Fujitani N; Furukawa J; Araki K; Fujioka T; Takegawa Y; Piao J; Nishioka T; Tamura T; Nikaido T; Ito M; Nakamura Y; Shinohara Y Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2105-10. PubMed ID: 23345451 [TBL] [Abstract][Full Text] [Related]
2. Glycomics of human embryonic stem cells and human induced pluripotent stem cells. Furukawa JI; Okada K; Shinohara Y Glycoconj J; 2017 Dec; 34(6):807-815. PubMed ID: 29150735 [TBL] [Abstract][Full Text] [Related]
3. Glycomics of human embryonic stem cells and human induced pluripotent stem cells. Furukawa J; Okada K; Shinohara Y Glycoconj J; 2016 Oct; 33(5):707-15. PubMed ID: 27318474 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of total serum glycome in human and mouse. Yoshida Y; Furukawa JI; Naito S; Higashino K; Numata Y; Shinohara Y Proteomics; 2016 Nov; 16(21):2747-2758. PubMed ID: 27601404 [TBL] [Abstract][Full Text] [Related]
6. Qualitative and quantitative cellular glycomics of glycosphingolipids based on rhodococcal endoglycosylceramidase-assisted glycan cleavage, glycoblotting-assisted sample preparation, and matrix-assisted laser desorption ionization tandem time-of-flight mass spectrometry analysis. Fujitani N; Takegawa Y; Ishibashi Y; Araki K; Furukawa JI; Mitsutake S; Igarashi Y; Ito M; Shinohara Y J Biol Chem; 2011 Dec; 286(48):41669-41679. PubMed ID: 21965662 [TBL] [Abstract][Full Text] [Related]
7. Toolbox Accelerating Glycomics (TAG): Glycan Annotation from MALDI-TOF MS Spectra and Mapping Expression Variation to Biosynthetic Pathways. Miura N; Hanamatsu H; Yokota I; Okada K; Furukawa JI; Shinohara Y Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32998456 [TBL] [Abstract][Full Text] [Related]
8. Quantitative glycomics monitoring of induced pluripotent- and embryonic stem cells during neuronal differentiation. Terashima M; Amano M; Onodera T; Nishimura S; Iwasaki N Stem Cell Res; 2014 Nov; 13(3 Pt A):454-64. PubMed ID: 25460606 [TBL] [Abstract][Full Text] [Related]
9. Sensitive and robust MALDI-TOF-MS glycomics analysis enabled by Girard's reagent T on-target derivatization (GTOD) of reducing glycans. Zhang Y; Wang B; Jin W; Wen Y; Nan L; Yang M; Liu R; Zhu Y; Wang C; Huang L; Song X; Wang Z Anal Chim Acta; 2019 Feb; 1048():105-114. PubMed ID: 30598139 [TBL] [Abstract][Full Text] [Related]
10. Integrated mass spectrometric strategy for characterizing the glycans from glycosphingolipids and glycoproteins: direct identification of sialyl Le(x) in mice. Parry S; Ledger V; Tissot B; Haslam SM; Scott J; Morris HR; Dell A Glycobiology; 2007 Jun; 17(6):646-54. PubMed ID: 17341505 [TBL] [Abstract][Full Text] [Related]
11. Functional glycomic analysis of human milk glycans reveals the presence of virus receptors and embryonic stem cell biomarkers. Yu Y; Mishra S; Song X; Lasanajak Y; Bradley KC; Tappert MM; Air GM; Steinhauer DA; Halder S; Cotmore S; Tattersall P; Agbandje-McKenna M; Cummings RD; Smith DF J Biol Chem; 2012 Dec; 287(53):44784-99. PubMed ID: 23115247 [TBL] [Abstract][Full Text] [Related]
12. Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis. Pripuzova NS; Getie-Kebtie M; Grunseich C; Sweeney C; Malech H; Alterman MA Stem Cell Res; 2015 May; 14(3):323-38. PubMed ID: 25840413 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive glycome profiling of Huntington's disease transgenic mice. Gizaw ST; Koda T; Amano M; Kamimura K; Ohashi T; Hinou H; Nishimura S Biochim Biophys Acta; 2015 Sep; 1850(9):1704-18. PubMed ID: 25907331 [TBL] [Abstract][Full Text] [Related]
14. Glycolipid dynamics in generation and differentiation of induced pluripotent stem cells. Ojima T; Shibata E; Saito S; Toyoda M; Nakajima H; Yamazaki-Inoue M; Miyagawa Y; Kiyokawa N; Fujimoto JI; Sato T; Umezawa A Sci Rep; 2015 Oct; 5():14988. PubMed ID: 26477663 [TBL] [Abstract][Full Text] [Related]
15. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. Ghosh Z; Wilson KD; Wu Y; Hu S; Quertermous T; Wu JC PLoS One; 2010 Feb; 5(2):e8975. PubMed ID: 20126639 [TBL] [Abstract][Full Text] [Related]
16. The N-glycome of human embryonic stem cells. Satomaa T; Heiskanen A; Mikkola M; Olsson C; Blomqvist M; Tiittanen M; Jaatinen T; Aitio O; Olonen A; Helin J; Hiltunen J; Natunen J; Tuuri T; Otonkoski T; Saarinen J; Laine J BMC Cell Biol; 2009 Jun; 10():42. PubMed ID: 19490625 [TBL] [Abstract][Full Text] [Related]
17. Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells. Toyoda H; Nagai Y; Kojima A; Kinoshita-Toyoda A Glycoconj J; 2017 Dec; 34(6):817-823. PubMed ID: 28980094 [TBL] [Abstract][Full Text] [Related]
18. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. Uosaki H; Fukushima H; Takeuchi A; Matsuoka S; Nakatsuji N; Yamanaka S; Yamashita JK PLoS One; 2011; 6(8):e23657. PubMed ID: 21876760 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Residual Human-Induced Pluripotent Stem Cells in Human Chondrocytes by Cell Type-Specific Glycosphingolipid Glycome Analysis Based on the Aminolysis-SALSA Technique. Miyazaki T; Hanamatsu H; Xu L; Onodera T; Furukawa JI; Homan K; Baba R; Kawasaki T; Iwasaki N Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905707 [TBL] [Abstract][Full Text] [Related]
20. A glycomics approach to the discovery of potential cancer biomarkers. An HJ; Lebrilla CB Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]